Celcuity is a clinical-stage biotechnology company deeply engaged in developing targeted oncology therapies. The Celcuity digital transformation prioritizes robust clinical trial execution and rigorous regulatory compliance for its lead product candidate, gedatolisib. Their approach specifically integrates scientific insight from the CELsignia platform with late-stage drug development processes.
This intensive digital transformation creates critical dependencies on data integrity across various systems and workflows. Challenges emerge when clinical data does not propagate accurately or when regulatory documentation requires manual reconciliation across platforms. This page analyzes specific initiatives Celcuity undertakes and identifies precise control points where operational breakdowns occur.
Celcuity Snapshot
Headquarters: Minneapolis, United States
Number of employees: 155
Public or private: Public
Business model: B2B
Website: http://www.celcuity.com
Celcuity ICP and Buying Roles
Celcuity sells to highly regulated research organizations and specialized pharmaceutical development firms.
Who drives buying decisions
- Chief Medical Officer → Clinical development strategy
- Vice President of Regulatory Affairs → Regulatory submission compliance
- Vice President of Clinical Operations → Clinical trial execution oversight
- Vice President of Quality Assurance and Process Development → Quality system enforcement
Key Digital Transformation Initiatives at Celcuity (At a Glance)
- Modernizing clinical data management systems: Centralizing trial data collection and validation workflows.
- Implementing electronic Quality Management Systems: Automating GxP training and document control processes.
- Streamlining regulatory submission platforms: Consolidating document assembly and lifecycle management for FDA filings.
- Integrating Laboratory Information Management Systems: Tracking samples and assay results from the CELsignia platform.
- Digitizing clinical trial supply chain: Managing investigational product logistics across international sites.
Where Celcuity’s Digital Transformation Creates Sales Opportunities
| Vendor Type | Where to Sell (DT Initiative + Challenge) | Buyer / Owner | Solution Approach |
|---|---|---|---|
| Clinical Data Management Platforms | Clinical data management system modernization: collected data does not validate against study protocols before database lock. | Senior Manager, Clinical Data Management | Validate incoming clinical data against predefined study parameters. |
| Clinical data management system modernization: Case Report Form (CRF) data does not transfer correctly into the central database. | Executive Director, Clinical Data Management | Enforce accurate data transfer from CRFs into the clinical database. | |
| Clinical data management system modernization: external lab data requires manual reconciliation before system integration. | Vice President, Clinical Operations | Standardize data formats for automated integration of external laboratory results. | |
| Electronic QMS Solutions | Electronic Quality Management System implementation: GxP training records do not sync across learning management systems. | Director, Quality Management Systems | Centralize training record management across GxP curricula. |
| Electronic Quality Management System implementation: controlled documents do not route for approval based on defined workflows. | Vice President, Quality Assurance and Process Development | Enforce automated routing for document approvals based on departmental roles. | |
| Electronic Quality Management System implementation: audit trails are incomplete for regulatory inspection readiness. | Quality Assurance Manager | Generate complete and immutable audit trails for all QMS activities. | |
| Regulatory Information Management (RIM) Systems | Streamlining regulatory submission platforms: submission documents do not compile accurately for FDA eCTD format. | Vice President, Regulatory Affairs | Validate regulatory documents against eCTD publishing standards. |
| Streamlining regulatory submission platforms: version control failures create discrepancies in final submission packages. | Regulatory Affairs Specialist | Enforce strict version control on all regulatory submission documents. | |
| Streamlining regulatory submission platforms: previous submission data is not retrievable for new filings. | General Counsel, Vice President, Regulatory Affairs | Centralize storage and retrieval of all historical regulatory submission data. | |
| Laboratory Informatics Systems | Integrating Laboratory Information Management Systems: CELsignia assay results do not transfer automatically to the central research database. | Chief Science Officer, Vice President, Pharmaceutical Development | Route CELsignia assay data directly into the central research database. |
| Integrating Laboratory Information Management Systems: sample tracking failures lead to missing chain-of-custody records. | Laboratory Manager | Enforce automated sample tracking and chain-of-custody documentation. | |
| Clinical Supply Chain Management | Digitizing clinical trial supply chain: investigational product inventory levels are not visible across trial sites. | Vice President, Program Management | Monitor real-time inventory levels of investigational products across clinical sites. |
| Digitizing clinical trial supply chain: drug expiry dates are not tracked across various storage locations. | Clinical Supply Chain Manager | Detect expiring drug inventory across all storage and distribution points. |
Identify when companies like Celcuity are in-market for your solutions.
Spot buying signals, find the right prospects, enrich your data, and reach out with relevant messaging at the right time.
What makes this Celcuity’s digital transformation unique
Celcuity's digital transformation centers on managing complex biological data and regulatory pathways specific to oncology drug development. They depend heavily on the integrity of clinical trial data and the precision of regulatory submissions, a critical aspect for a pre-commercial biotech company with a lead asset in Phase 3. This makes their transformation different from typical enterprises, requiring systems that strictly adhere to GxP compliance and support highly specialized scientific workflows like their CELsignia platform. The stakes involve patient outcomes and FDA approval, which elevates the need for robust and verifiable digital infrastructure.
Celcuity’s Digital Transformation: Operational Breakdown
DT Initiative 1: Clinical Data Management System Modernization
What the company is doing
Celcuity modernizes clinical data management systems to standardize data collection from global clinical trials. This initiative involves centralizing Electronic Data Capture (EDC) system outputs and integrating external data sources. They manage timelines and quality of clinical data management deliverables for assigned studies.
Who owns this
- Executive Director, Clinical Data Management
- Senior Manager, Clinical Data Management
- Vice President, Clinical Operations
Where It Fails
- Clinical trial data from Contract Research Organizations (CROs) requires manual validation before ingest into the central system.
- Discrepancies appear in patient records when data transfers from various EDC systems to the main clinical database.
- External lab results fail to reconcile with internally collected clinical data points during study database lock procedures.
Talk track
Noticed Celcuity is modernizing clinical data management workflows. Been looking at how some biotech teams validate incoming trial data against predefined study parameters instead of manual review, can share what’s working if useful.
DT Initiative 2: Electronic Quality Management System (eQMS) Implementation
What the company is doing
Celcuity implements an electronic Quality Management System to manage GxP-related training and documentation. This system standardizes the creation, review, and approval of controlled documents. They ensure compliance with FDA, ISO, and GxP regulatory requirements.
Who owns this
- Vice President, Quality Assurance and Process Development
- Director, Quality Management Systems
- Quality Assurance Manager
Where It Fails
- GxP training curricula do not automatically update when Standard Operating Procedures (SOPs) undergo revision.
- Controlled documents remain in draft status due to failures in automated routing for required signatures.
- Regulatory inspections find incomplete audit trails for quality events and corrective actions.
Talk track
Saw Celcuity implements electronic Quality Management Systems. Been looking at how some biopharma companies centralize training record management across GxP curricula instead of siloed systems, happy to share what we’re seeing.
DT Initiative 3: Regulatory Submission and Archiving Platform
What the company is doing
Celcuity streamlines regulatory submission platforms to compile and manage New Drug Application (NDA) documents. This involves centralizing the archiving and retrieval of submission-related data for future filings. They prepare for FDA Real-Time Oncology Review (RTOR) and supplemental New Drug Application (sNDA) submissions.
Who owns this
- Vice President, Regulatory Affairs
- General Counsel
- Regulatory Affairs Specialist
Where It Fails
- Submission documents fail validation checks against FDA eCTD specifications before final assembly.
- Previous regulatory responses are difficult to retrieve, delaying responses to agency information requests.
- Version control errors lead to incorrect document versions included in final submission packages.
Talk track
Looks like Celcuity is streamlining regulatory submission platforms. Been seeing teams validate regulatory documents against eCTD publishing standards automatically instead of manual checks, can share what’s working if useful.
DT Initiative 4: Laboratory Information Management System (LIMS) for CELsignia Platform
What the company is doing
Celcuity integrates Laboratory Information Management Systems to track samples and manage assay results from their CELsignia platform. This system handles the inflow of living tumor cells and the quantification of signaling activity levels. It ensures data integrity from laboratory experiments through to downstream analysis.
Who owns this
- Chief Science Officer
- Vice President, Pharmaceutical Development
- Laboratory Medical Director
Where It Fails
- CELsignia assay results do not automatically link to specific patient clinical trial IDs.
- Laboratory sample chain-of-custody records show gaps from receipt to final analysis.
- Raw instrument data from cell analysis devices are not consistently stored in a centralized format.
Talk track
Noticed Celcuity integrates Laboratory Information Management Systems for its CELsignia platform. Been looking at how some research teams route assay data directly into central research databases instead of manual entry, happy to share what we’re seeing.
DT Initiative 5: Digitizing Clinical Trial Supply Chain
What the company is doing
Celcuity digitizes its clinical trial supply chain to manage the distribution and inventory of investigational products. This initiative oversees product logistics across multiple international trial sites. They implement systems to track manufacturing readiness and product availability.
Who owns this
- Vice President, Program Management
- Clinical Supply Chain Manager
- Head of Clinical Operations
Where It Fails
- Investigational product inventory levels are not accurately reflected across various clinical trial sites.
- Drug expiry dates are not consistently tracked in the global supply chain management system.
- Shipment delays for investigational products block patient enrollment at certain clinical sites.
Talk track
Saw Celcuity digitizes its clinical trial supply chain. Been looking at how some biopharma companies monitor real-time inventory levels of investigational products across clinical sites instead of periodic reports, can share what’s working if useful.
Who Should Target Celcuity Right Now
This account is relevant for:
- Clinical data management software providers
- GxP-compliant Quality Management System (QMS) vendors
- Regulatory information management (RIM) and eCTD publishing platforms
- Laboratory Information Management System (LIMS) solutions
- Clinical trial supply chain and inventory management software
- Biotech-specific data integration platforms
Not a fit for:
- Generic ERP systems without biotech-specific modules
- Basic marketing automation platforms
- General IT infrastructure services
- Consumer-facing e-commerce solutions
When Celcuity Is Worth Prioritizing
Prioritize if:
- You sell clinical data validation tools that automate data quality checks from CROs.
- You sell GxP-compliant learning management systems that integrate with eQMS for SOP updates.
- You sell regulatory publishing software that validates documents against FDA eCTD specifications.
- You sell LIMS platforms that automatically integrate complex assay results with clinical trial data.
- You sell clinical supply chain software that provides real-time visibility into investigational product inventory across global sites.
- You sell solutions that enforce consistent data storage from laboratory instruments.
Deprioritize if:
- Your solution does not address specific GxP or FDA regulatory compliance challenges.
- Your product is limited to basic data storage with no integration capabilities for clinical or lab systems.
- Your offering lacks specialized features for managing pharmaceutical development or clinical trials.
Who Can Sell to Celcuity Right Now
Clinical Data Management Platforms
Medidata Solutions - This company provides cloud-based solutions for clinical development, including EDC, clinical data management, and clinical trial management.
Why they are relevant: Discrepancies appear in patient records when data transfers from various EDC systems to the main clinical database. Medidata Solutions can enforce consistent data collection standards and streamline data flows between different systems, reducing manual intervention in reconciliation.
Veeva Systems - This company offers a suite of cloud software for the life sciences industry, including clinical data management applications.
Why they are relevant: Clinical trial data from Contract Research Organizations (CROs) requires manual validation before ingest into the central system. Veeva's clinical suite can automate the ingestion and validation of CRO data, ensuring data quality and accelerating database lock processes.
IQVIA Technologies - This company offers technology solutions for clinical development, including integrated clinical data management systems.
Why they are relevant: External lab results fail to reconcile with internally collected clinical data points during study database lock procedures. IQVIA's platforms can standardize external lab data formats and automate reconciliation, preventing delays in clinical trial reporting.
Electronic Quality Management System (eQMS) Vendors
Veeva Systems - This company provides cloud-based QMS solutions designed specifically for the life sciences industry, managing quality processes and compliance.
Why they are relevant: GxP training curricula do not automatically update when Standard Operating Procedures (SOPs) undergo revision. Veeva QMS can link training content directly to controlled documents, ensuring curricula automatically reflect the latest SOP versions and regulatory requirements.
MasterControl - This company offers a comprehensive quality management system that automates GxP processes for highly regulated environments.
Why they are relevant: Controlled documents remain in draft status due to failures in automated routing for required signatures. MasterControl can enforce automated routing and approval workflows for all GxP documents, accelerating the review cycle and ensuring compliance.
ComplianceQuest - This company provides AI-driven, cloud-native QMS solutions for biotechnology organizations to meet regulatory requirements and streamline quality workflows.
Why they are relevant: Regulatory inspections find incomplete audit trails for quality events and corrective actions. ComplianceQuest can generate immutable, detailed audit trails for every QMS activity, ensuring full traceability and readiness for regulatory scrutiny.
Regulatory Information Management (RIM) Systems
Veeva Systems - This company offers a unified suite of RIM applications to manage global regulatory submissions and product registrations.
Why they are relevant: Submission documents fail validation checks against FDA eCTD specifications before final assembly. Veeva RIM can automate eCTD publishing and validation, preventing errors and ensuring submissions meet regulatory technical requirements.
Extedo - This company provides software and services for regulatory information management and electronic submissions in the life sciences.
Why they are relevant: Previous regulatory responses are difficult to retrieve, delaying responses to agency information requests. Extedo's solutions can centralize and index all historical regulatory correspondence and data, enabling quick retrieval for new filings.
ArisGlobal - This company offers a comprehensive suite for drug development, including solutions for regulatory affairs and safety.
Why they are relevant: Version control errors lead to incorrect document versions included in final submission packages. ArisGlobal’s regulatory platform can enforce strict version control and document management, ensuring only approved versions are used in submissions.
Laboratory Information Management Systems (LIMS)
Thermo Fisher Scientific (SampleManager LIMS) - This company provides LIMS solutions for various industries, including life sciences, managing lab workflows and data.
Why they are relevant: CELsignia assay results do not automatically link to specific patient clinical trial IDs. SampleManager LIMS can integrate directly with CELsignia instruments to automatically associate assay data with patient identifiers, ensuring data traceability.
LabWare - This company offers LIMS and Electronic Lab Notebook (ELN) solutions for managing laboratory operations and scientific data.
Why they are relevant: Laboratory sample chain-of-custody records show gaps from receipt to final analysis. LabWare LIMS can automate sample tracking and generate complete chain-of-custody documentation, ensuring regulatory compliance and data integrity.
StarLIMS - This company provides enterprise LIMS solutions designed for highly regulated environments, including biotech and pharma.
Why they are relevant: Raw instrument data from cell analysis devices are not consistently stored in a centralized format. StarLIMS can standardize the capture and storage of raw instrument data, providing a single, accessible repository for all laboratory outputs.
Clinical Trial Supply Chain Management Platforms
TraceLink - This company provides digital supply chain solutions for the pharmaceutical industry, focusing on traceability and compliance.
Why they are relevant: Investigational product inventory levels are not accurately reflected across various clinical trial sites. TraceLink can provide real-time visibility into inventory levels across the global supply chain, preventing stockouts and optimizing distribution.
Arvato Supply Chain Solutions - This company offers specialized logistics and supply chain services for the healthcare and pharmaceutical sector.
Why they are relevant: Drug expiry dates are not consistently tracked in the global supply chain management system. Arvato's systems can automate the monitoring of expiry dates for investigational products, reducing waste and ensuring product viability.
World Courier (AmerisourceBergen) - This company provides specialized logistics and transport services for clinical trials and life sciences products.
Why they are relevant: Shipment delays for investigational products block patient enrollment at certain clinical sites. World Courier can optimize cold chain logistics and delivery routes for sensitive materials, ensuring timely arrival and minimizing trial disruptions.
Final Take
Celcuity scales complex clinical trial operations and regulatory submissions for its oncology drug development. Breakdowns are visible in manual data reconciliation, non-automated document workflows, and fragmented supply chain visibility. This account is a strong fit for solutions that enforce GxP data integrity, automate regulatory compliance processes, and centralize clinical and laboratory data management.
Identify buying signals from digital transformation at your target companies and find those already in-market.
Find the right contacts and use tailored messages to reach out with context.